US FDA proposes streamlined registration rule for multi-site drug manufacturers

US FDA proposes a new rule to simplify drug manufacturer registration, improve supply chain transparency and strengthen oversight of global pharmaceutical networks.

Raccontata dathehindubusinessline.com